Various packages of the weight-loss drug Wegovy from the pharmaceutical company Novo Nordisk lie on the sales counter in a Danish pharmacy. The drug, which has caused quite a stir, is due to be launched on the German market at the end of July 2023. STEFFEN TRUMPF/PICTURE ALLIANCE VIA GETTY IMAGES.
Popular weight loss and diabetes drugs, Ozempic and Wegovy, have reportedly caused stomach paralysis in some users.
“Life-altering side effects are causing some to question whether the benefits of the Novo Nordisk A/S (NYSE:NVO) produced medications outweigh the costs,” said CNN.
Sign up to read this article
Read news from 100's of titles, curated specifically for you.